Cargando…
Conformation-stabilizing ELISA and cell-based assays reveal patient subgroups targeting three different epitopes of AGO1 antibodies
Autoantibodies (Abs) are biomarkers for many disease conditions and are increasingly used to facilitate diagnosis and treatment decisions. To guarantee high sensitivity and specificity, the choice of their detection method is crucial. Via cell-based assays, we recently found 21 patients with neurolo...
Autores principales: | Moritz, Christian P., Do, Le-Duy, Tholance, Yannick, Vallayer, Pierre-Baptiste, Rogemond, Véronique, Joubert, Bastien, Ferraud, Karine, La Marca, Coralie, Camdessanché, Jean-Philippe, Honnorat, Jérôme, Antoine, Jean-Christophe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630334/ https://www.ncbi.nlm.nih.gov/pubmed/36341350 http://dx.doi.org/10.3389/fimmu.2022.972161 |
Ejemplares similares
-
CIDP Antibodies Target Junction Proteins and Identify Patient Subgroups: An Autoantigenomic Approach
por: Moritz, Christian P., et al.
Publicado: (2021) -
Argonaute Autoantibodies as Biomarkers in Autoimmune Neurologic Diseases
por: Do, Le-Duy, et al.
Publicado: (2021) -
The pattern and diagnostic criteria of sensory neuronopathy: a case–control study
por: Camdessanché, Jean-Philippe, et al.
Publicado: (2009) -
COVID-19 and Guillain-Barré syndrome: Response()
por: Camdessanché, Jean-Philippe, et al.
Publicado: (2020) -
Multiplex family with GAD65-Abs neurologic syndromes
por: Belbezier, Aude, et al.
Publicado: (2017)